Evaluating the Ups and Downs of Shuttle Pharmaceuticals Holdings Inc’s (SHPH) Stock

The stock of Shuttle Pharmaceuticals Holdings Inc (SHPH) has seen a 26.13% increase in the past week, with a -8.86% drop in the past month, and a -49.56% decrease in the past quarter. The volatility ratio for the week is 6.34%, and the volatility levels for the past 30 days are at 5.66% for SHPH. The simple moving average for the last 20 days is 11.05% for SHPH stock, with a simple moving average of -74.38% for the last 200 days.

Is It Worth Investing in Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH) Right Now?

The 36-month beta value for SHPH is also noteworthy at 0.42.

The public float for SHPH is 6.07M, and at present, short sellers hold a 11.51% of that float. The average trading volume of SHPH on June 10, 2025 was 4.69M shares.

SHPH) stock’s latest price update

The stock price of Shuttle Pharmaceuticals Holdings Inc (NASDAQ: SHPH) has surged by 9.79 when compared to previous closing price of 0.19, but the company has seen a 26.13% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-04 that GAITHERSBURG, Md., June 04, 2025 (GLOBE NEWSWIRE) — Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced the appointment of George Scorsis as the Chairman of the Board of Directors. Mr. Scorsis has served as director of the Company since February 2025.

SHPH Trading at -20.39% from the 50-Day Moving Average

After a stumble in the market that brought SHPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.07% of loss for the given period.

#####

#####

Stock Fundamentals for SHPH

Current profitability levels for the company are sitting at:

  • -1611.44 for the present operating margin
  • -0.17 for the gross margin

The net margin for Shuttle Pharmaceuticals Holdings Inc stands at -1820.94. The total capital return value is set at -2.63. Equity return is now at value -346.19, with -208.00 for asset returns.

Based on Shuttle Pharmaceuticals Holdings Inc (SHPH), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -7.8. The debt to equity ratio resting at 0.34. The interest coverage ratio of the stock is -10.81.

Currently, EBITDA for the company is -7.7 billion with net debt to EBITDA at 0.36. When we switch over and look at the enterprise to sales, we see a ratio of -173.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.78.

Conclusion

In summary, Shuttle Pharmaceuticals Holdings Inc (SHPH) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts

favicon-nh
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.